Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen
about
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsHepatitis C Virus, Insulin Resistance, and SteatosisType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightClinical Advances in Fibrosis Progression of Chronic Hepatitis B and CSteatosis and hepatitis CFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVTransitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decadesHuman immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Non-alcoholic fatty liver disease: An expanded reviewDiabetes and Hepatitis C: A Two-Way Association.Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity.Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.Hepatitis C Virus Selectively Alters the Intracellular Localization of Desmosterol.Retrospective study of the associations between hepatitis C virus infection and metabolic factors.Hepatitis C virus and cardiovascular: A review.Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients.A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesNonalcoholic fatty liver disease and decreased bone mineral density: is there a link?Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.Histopathology of hepatitis C in children, a systematic review: implications for treatment.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Activity-based profiling of the proteasome pathway during hepatitis C virus infection.The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis.TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.Direct-acting antiviral agents against hepatitis C virus and lipid metabolism.NAFLD: Is There Anything New under the Sun?Hepatitis C Virus: Viral Quasispecies and Genotypes.Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.Hepatitis C in nonobese nondiabetic patients: Insulin resistance and the metabolic syndrome make a difference.
P2860
Q26745576-DE8DB6C5-D113-4F2B-9841-4A8FA0E3702BQ26751755-D15994B2-1477-4852-8526-42111E1A06CCQ26752583-01673E15-1D75-4648-86B5-C49D7FD6EDD4Q26781789-39AA245B-9827-4063-8B03-BF0F2DB6BE9AQ26798101-A88E1906-8B81-42D6-937C-260036F3DB2FQ28079826-8EC69A26-AE07-46CD-8F2A-87053876ACCDQ28088798-FD4686F8-1220-42A7-AFF9-2729E505BB5EQ31149395-19A92D0E-F8AE-441F-95CC-25D03703AD00Q33789868-25A2E5CF-3EB7-4CA0-970E-CA5BCECCE6A5Q36056076-FBD3C178-435F-495A-A95A-93DAB431A6C5Q36248995-021949A1-B4CF-49BD-A88A-6D9BB85B78B8Q36364689-986E13D2-6474-4564-A7CC-F8839278EEB4Q37087800-F74E8594-4E82-4AEF-9F46-02E58AF409EBQ37259939-D678AEED-9C77-4672-9742-1546C653D058Q37374053-8AA846F4-AC06-4E88-B78C-2F07CD5F1627Q37610905-BEB459A2-98E7-4F6F-B648-6B41E1860E66Q37612864-CDCEC71B-CA22-42E0-894E-7365DC3B3E2DQ37703437-C79D74A8-E71C-400A-AE85-55FB8A042396Q38500120-43931AB9-567C-4122-BF01-21740A5F6ACCQ38542209-E2FF9B12-C244-454A-BCC5-C8873DDD3CA5Q38552521-A9C8128C-ACFB-4AC7-BD5E-0861E2D1C633Q38752520-0139879B-4DA8-4871-82EC-22842A53018EQ38840313-80F4B563-3E92-4799-8AF3-39B73F0A9A37Q40414261-D9CBDD56-B97A-403F-A08C-44DEB4AA35C6Q40482870-A7F9515D-0FAA-4BA3-9496-D650BC719C48Q42349373-E494E7BE-9AC3-4F36-90AF-D44F466FC85DQ42365749-7E974ACD-F65F-4574-B1C0-ED3B5E93C42DQ47260983-87C47E94-B31A-48B7-BA67-0262C00E2670Q49959253-6CC639E2-20B6-49A1-9DB7-C9B5A8C64BD0Q50752289-86702296-ABC9-4890-9BE1-53B9E7E17743
P2860
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathogenesis and significance ...... ategy of a successful pathogen
@ast
Pathogenesis and significance ...... ategy of a successful pathogen
@en
Pathogenesis and significance ...... ategy of a successful pathogen
@nl
type
label
Pathogenesis and significance ...... ategy of a successful pathogen
@ast
Pathogenesis and significance ...... ategy of a successful pathogen
@en
Pathogenesis and significance ...... ategy of a successful pathogen
@nl
prefLabel
Pathogenesis and significance ...... ategy of a successful pathogen
@ast
Pathogenesis and significance ...... ategy of a successful pathogen
@en
Pathogenesis and significance ...... ategy of a successful pathogen
@nl
P2093
P2860
P50
P3181
P356
P1476
Pathogenesis and significance ...... ategy of a successful pathogen
@en
P2093
Dante Romagnoli
Enrica Baldelli
Luciano Restivo
Luigi Elio Adinolfi
Paola Loria
P2860
P304
P3181
P356
10.3748/WJG.V20.I23.7089
P407
P577
2014-06-01T00:00:00Z